DOJ OKs Supply Chain 'Control Tower' Collaboration Against COVID-19 Drug Shortages
AmerisourceBergen, McKesson, Cardinal and others can help FEMA deliver hydroxychloroquine and manage critical-drugs supply chain without running afoul of federal antitrust law.
You may also be interested in...
Industry wonders how emergency agency's COVID-19 public-private partnerships will fit in with the others.
Companies are shielded from antitrust concerns by Justice Department as they jointly prepare to manufacture whichever monoclonal-antibody-based coronavirus therapies emerge from development.
FDA Commissioner Hahn says industry needs to work with the agency to establish a link to more detailed supply chain information.